Entity Details

Primary name COX2_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionP00403
EntryNameCOX2_HUMAN
FullNameCytochrome c oxidase subunit 2
TaxID9606
Evidenceevidence at protein level
Length227
SequenceStatuscomplete
DateCreated1986-07-21
DateModified2021-06-02

Ontological Relatives

GenesCOX2

GO terms

Show/Hide Table
GOName
GO:0004129 cytochrome-c oxidase activity
GO:0005507 copper ion binding
GO:0005739 mitochondrion
GO:0005743 mitochondrial inner membrane
GO:0006123 mitochondrial electron transport, cytochrome c to oxygen
GO:0007595 lactation
GO:0009409 response to cold
GO:0010729 positive regulation of hydrogen peroxide biosynthetic process
GO:0010940 positive regulation of necrotic cell death
GO:0016020 membrane
GO:0016021 integral component of membrane
GO:0042773 ATP synthesis coupled electron transport
GO:0045277 respiratory chain complex IV
GO:2001171 positive regulation of ATP biosynthetic process

Subcellular Location

Show/Hide Table
Subcellular Location
Mitochondrion inner membrane

Domains

Show/Hide Table
DomainNameCategoryType
IPR001505 Copper centre Cu(A)SiteBinding site
IPR002429 Cytochrome c oxidase subunit II-like C-terminalDomainDomain
IPR008972 CupredoxinFamilyHomologous superfamily
IPR011759 Cytochrome C oxidase subunit II, transmembrane domainDomainDomain
IPR014222 Cytochrome c oxidase, subunit IIDomainDomain
IPR034210 Cytochrome c oxidase subunit 2, C-terminalDomainDomain
IPR036257 Cytochrome C oxidase subunit II, transmembrane domain superfamilyFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
220110 OMIMMitochondrial complex IV deficiency (MT-C4D)A disorder of the mitochondrial respiratory chain with heterogeneous clinical manifestations, ranging from isolated myopathy to severe multisystem disease affecting several tissues and organs. Features include hypertrophic cardiomyopathy, hepatomegaly and liver dysfunction, hypotonia, muscle weakness, exercise intolerance, developmental delay, delayed motor development and mental retardation. Some affected individuals manifest a fatal hypertrophic cardiomyopathy resulting in neonatal death. A subset of patients manifest Leigh syndrome. The disease is caused by variants affecting the gene represented in this entry.

Drugs

Show/Hide Table
DrugNameSourceType
DB02659 Cholic AcidDrugbanksmall molecule
DB04464 N-FormylmethionineDrugbanksmall molecule
DB05412 TalmapimodDrugbanksmall molecule